Literature DB >> 18797986

Spinal cord compression in an adolescent with relapsed B-precursor acute lymphoblastic leukemia and mental neuropathy.

Elpis Mantadakis1, Aspasia Katragkou1, Eufrosini Papadaki2, Stefanos Papadhimitriou3, George Paterakis4, Eftichia Stiakaki1, Maria Kalmanti5.   

Abstract

The authors report a case of intraspinal mass associated with recurrence of B-precursor acute lymphoblastic leukemia in an adolescent male who presented with numb chin syndrome at initial diagnosis of the leukemia. The patient developed sensory changes, later on motor weakness, and eventually paraplegia. An emergent MRI scan showed an intraspinal mass at the level of T9 vertebra. Biopsy obtained during laminectomy revealed a mass composed of lymphoblasts immunophenotypically identical to the patient's known leukemia. Surgical decompression and dexamethasone were ineffective in restoration of the neurological deficits. Intraspinal extramedullary relapses should be considered in the differential diagnosis of leukemic patients with neurological symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 18797986     DOI: 10.1007/s12185-008-0159-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

1.  Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.

Authors:  H M Kantarjian; S O'Brien; T L Smith; J Cortes; F J Giles; M Beran; S Pierce; Y Huh; M Andreeff; C Koller; C S Ha; M J Keating; S Murphy; E J Freireich
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse.

Authors:  T L Carter; P M Watt; R Kumar; P R Burton; G H Reaman; H N Sather; D L Baker; U R Kees
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

3.  Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia.

Authors:  M Heyman; O Rasool; L Borgonovo Brandter; Y Liu; D Grandér; S Söderhäll; G Gustavsson; S Einhorn
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

4.  Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.

Authors:  Je-Hwan Lee; Seong-Jun Choi; Jung-Hee Lee; Miee Seol; Young-Shin Lee; Seong-Gil Ryu; Chan-Jeoung Park; Hyun-Sook Chi; Moo-Song Lee; SungCheol Yun; Jung-Shin Lee; Kyoo-Hyung Lee
Journal:  Haematologica       Date:  2005-10       Impact factor: 9.941

Review 5.  Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group.

Authors:  D Andrew Loblaw; James Perry; Alexandra Chambers; Normand J Laperriere
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

6.  Isolated extramedullary relapse of acute lymphoblastic leukemia presenting as an intraspinal mass.

Authors:  W L Hwang; J P Gau; H T Hu; J H Young
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

7.  Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome.

Authors:  U R Kees; P R Burton; C Lü; D L Baker
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

8.  Numb chin syndrome secondary to Burkitt's cell acute leukemia.

Authors:  Y Kuroda; F Fujiyama; T Ohyama; T Watanabe; C Endo; R Neshige; R Kakigi
Journal:  Neurology       Date:  1991-03       Impact factor: 9.910

9.  Numb chin syndrome as an initial symptom of acute lymphocytic leukemia: report of three cases.

Authors:  A Hiraki; S Nakamura; K Abe; Y Takenoshita; Y Horinouchi; M Shinohara; K Shirasuna
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-05

10.  Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.

Authors:  L Bomgaars; J R Geyer; J Franklin; G Dahl; J Park; N J Winick; R Klenke; S L Berg; S M Blaney
Journal:  J Clin Oncol       Date:  2004-10-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.